Cargando…
RhoA Signaling in Immune Cell Response and Cardiac Disease
Chronic inflammation, the activation of immune cells and their cross-talk with cardiomyocytes in the pathogenesis and progression of heart diseases has long been overlooked. However, with the latest research developments, it is increasingly accepted that a vicious cycle exists where cardiomyocytes r...
Autores principales: | Kilian, Lucia Sophie, Frank, Derk, Rangrez, Ashraf Yusuf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306393/ https://www.ncbi.nlm.nih.gov/pubmed/34359851 http://dx.doi.org/10.3390/cells10071681 |
Ejemplares similares
-
RhoA: a dubious molecule in cardiac pathophysiology
por: Kilian, Lucia Sophie, et al.
Publicado: (2021) -
Dysbindin is a potent inducer of RhoA–SRF-mediated cardiomyocyte hypertrophy
por: Rangrez, Ashraf Yusuf, et al.
Publicado: (2013) -
RhoA Signaling in Neurodegenerative Diseases
por: Schmidt, Sissel Ida, et al.
Publicado: (2022) -
Data on the role of cardiac α-actin (ACTC1) gene mutations on SRF-signaling
por: Rangrez, Ashraf Yusuf, et al.
Publicado: (2020) -
Histamine-induced biphasic activation of RhoA allows for persistent RhoA signaling
por: Zhang, Jason Z., et al.
Publicado: (2020)